Have a personal or library account? Click to login
Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique Cover

Prediction of drug-drug plasma protein binding interactions of resveratrol in combination with celecoxib and leflunomide by molecular docking combined with an ultrafiltration technique

Acta Pharmaceutica
Volume 70 (2020): Issue 1 (March 2020)
By: Peng Zhou and  Fang Hua  
Open Access
|Nov 2019

Authors

Peng Zhou

Department of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, Research Institute of Integrated Traditional Chinese and Western Medicine Anhui Academy of Chinese Medicine, Key Laboratory of Chinese Herbal Compound Formula in Anhui Province Hefei, China

Fang Hua

happyhf6941@sina.com

Pharmacy School, Anhui Xinhua University, Hefei, China
Natural Products Laboratory, International Joint Lab of Tea Chemistry and Health Effects, State Key Laboratory of Tea Plant Biology and Utilization Anhui Agricultural University, Hefei, China
DOI: https://doi.org/10.2478/acph-2019-0056 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 111 - 119
Accepted on: Mar 20, 2019
Published on: Nov 1, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
resveratrol,
celecoxib,
leflunomide,
molecular docking,
plasma protein binding,
ultrafiltration
Related subjects:
Pharmacy,
Pharmacy, other

© 2019 Peng Zhou, Fang Hua, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 70 (2020): Issue 1 (March 2020)Next article